# Neuphoria Therapeutics Inc.: Form 20-F for the period ended Jun 30, 2022

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 20-F
- Filed: 2022-10-14
- Accepted by EDGAR: Oct 14, 2022, 13:27 ET
- Period: 2022-06-30
- Accession: 0000950170-22-019563
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000095017022019563/bnox-20220630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000095017022019563/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-07-01 to 2022-06-30 | AUD 263.6k | ifrs-full:Revenue |
| Income tax | 12 months, 2021-07-01 to 2022-06-30 | −AUD 191.8k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-07-01 to 2022-06-30 | AUD 913.4k | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2021-07-01 to 2022-06-30 | −AUD 0.02 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-07-01 to 2022-06-30 | −AUD 0.02 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2021-07-01 to 2022-06-30 | −AUD 21.8m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-07-01 to 2022-06-30 | AUD 1.5k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2022-06-30 | AUD 33.6m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2022-06-30 | AUD 41.8m | ifrs-full:CurrentAssets |
| Total assets | at 2022-06-30 | AUD 65.3m | ifrs-full:Assets |
| Current liabilities | at 2022-06-30 | AUD 3.4m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2022-06-30 | AUD 8.4m | ifrs-full:Liabilities |
| Shares outstanding | at 2022-06-30 | 1,353,350,744 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000095017022019563/bnox-20220630.htm

Filed Oct 14, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-019563. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.